Bristol-Myers Squibb Co. (NYSE:BMY)
CAPS Rating:
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
Recs
Great dividend, nice pipeline, but uncertain short-term prospects. Really bad management but hopefully that will change.